Emerald Health Therapeutics Inc. (OTCMKTS:EMHTF) has made an important step in its Cannabis 2.0 strategy by launching a new rapid nanoemulsion-based spray, which is a unique offering in the cannabis marketplace in Canada.
Emerald launches new product line of nanoemulsion products
The Fast Action Spray is a unique formulation offering significant advantages over the current cannabis consumption formats in terms of predictability and convenience. The spray employs advanced technology in enhancing the absorption of cannabinoids by around 65% as well as offer predictable dosing. The product will consist of THC and CBD cannabinoids blended with some flavoring and certain terpenes.
The company will unveil the first product in June, which will be CBD 12.5 mg/mL plus myrcene combination. Other products include THC15mg/mL in combination with citrus and limonene and CBD 15mg/mL plus a combination of lemon and limonene that the company will launch by July. All the rapid onset nanoemulsion products will be bottled in 15 mL.
Emerald added natural terpenes to the product line because myrcene has analgesic, anxiolytic and anti-inflammatory properties. On the other hand, limonene also has analgesic, antidepressant, antioxidant, immunostimulating, and anti-inflammatory properties. The company is also in the process of developing other versions that are flavor-masked that will have little cannabis flavor.
Nanoemulsion enhanced bioavailability of CBD
Riaz Bandali, the CEO and President of the company, stated that the rapid action spray is a game-changing product in the Canadian cannabis industry. He added that the nanoemulsion product offers predictability, convenience, and attractive value compared to the absorbable cannabinoids. Bandali said that the product will offer adult-use and medical consumers a unique alternative relative to edible or inhaled products to get the desired outcomes.
The product has received massive interest from various distribution boards in different provinces, and the company is now moving fast to get the product available in the market. The company’s nanoemulsion products use smaller cannabinoids that are quickly absorbed into the bloodstream, thus minimizing the need for the breakdown, which thus increases the effects and bioavailability of the cannabinoids.